Issue 4/2012

  • Can bioeconomy save the planet?

    In this issue:

    • Swiss Biotech Report reveals more investment in sector
    • Danes kick-off psychiatric genomics research hub
    • Wellcome Trust to aid UK biotech with £200m in funding
    • Analytica 2012 in Munich: Update on bioanalytics
    • Janus to commercialise inclusion body drug delivery system
    • Mabion announces IPO on Warsaw Stock Exchange
    • Intratumour heterogeneity challenges biomarker approach

Volume 2014

Volume 2013

Volume 2012

© 2007-2015 BIOCOM

http://www.european-biotechnology-news.com/magazine/ebsin/2012/4/pos/1.html?sort=asc&cHash=bfd90e2d54056358af1b4a091bcb4f71

Kurszettel

Alle Kurse

TOP

  • CYTOS0.32 CHF14.29%
  • SANTHERA92.00 CHF5.75%
  • SARTORIUS106.00 EUR4.07%

FLOP

  • THERAMETRICS0.06 CHF-14.29%
  • EPIGENOMICS5.07 EUR-7.31%
  • 4SC0.85 EUR-6.59%

TOP

  • ADDEX3.56 CHF52.8%
  • CYTOS0.32 CHF45.5%
  • BB BIOTECH244.00 EUR23.3%

FLOP

  • ACTELION96.95 CHF-18.3%
  • THERAMETRICS0.06 CHF-14.3%
  • MAGFORCE4.65 EUR-13.2%

TOP

  • SANTHERA92.00 CHF2217.4%
  • BB BIOTECH244.00 EUR102.2%
  • CO.DON2.30 EUR60.8%

FLOP

  • CYTOS0.32 CHF-90.2%
  • MOLOGEN5.82 EUR-49.8%
  • 4SC0.85 EUR-47.2%

No liability assumed, Date: 26.01.2015